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Advances in Brief
Feline Immunodeficiency Virus Integration in B-Cell Lymphoma Identifies a
Candidate Tumor Suppressor Gene on Human Chromosome 15q151
Julia Beatty,2,3 Anne Terry,3 Julie MacDonald, Elizabeth Gault, Stan Cevario, Stephen J. O’Brien, Ewan Cameron,
and James C. Neil4
Molecular Oncology Laboratory, Institute of Comparative Medicine, University of Glasgow Veterinary School, Bearsden, Glasgow, Scotland G61 1QH [J. B., A. T., J. M., E. G.,
E. C., J. C. N.], and Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702 [S. C., S. J. O.]
Abstract
Infection with immunosuppressive lentiviruses is associated with in-
creased cancer risk, but most studies have implicated indirect mechanisms
as the tumor cells generally lack integrated viral sequences. An exception
was found in a B-cell lymphoma (Q254) where the tumor cells contained
a single integrated feline immunodeficiency virus genome. Additional
analysis now indicates that feline immunodeficiency virus integration in
lymphoma Q254 resulted in promoter insertion and truncation of a con-
served gene on feline chromosome B3, whereas the unaffected allele of the
gene appeared to be transcriptionally down-regulated. The orthologous
human gene (FLJ12973), is expressed ubiquitously and encodes a WD-
repeat protein with structural similarity to DDB2, the small subunit of the
xeroderma pigmentosum XP-E complex. Moreover, the gene is located
within a region of frequent tumor-specific deletions on chromosome
15q15. These observations demonstrate the direct mutagenic potential of
the lentiviruses and identify a new candidate tumor suppressor gene.
Introduction
Retrovirus-induced cancers frequently involve cis-activation of
host cell oncogenes at the sites of proviral insertion (1). Tumor
suppressor gene inactivation is a rarer consequence, but several no-
table examples include the p53 gene, where biallelic retroviral inac-
tivation provided an early clue to its tumor suppressor status (2).
However, the importance of insertional mutagenesis as a carcinogenic
mechanism has been established only for the simple , , and 
retroviruses. Tumors associated with HIV and related lentiviruses
have generally been found to lack viral sequences, suggesting that the
tumor predisposition conferred by this subfamily of retroviruses is
because of indirect mechanisms. Most HIV-1-associated lymphomas
are thought to occur secondary to polyclonal B-cell activation and
infection with oncogenic viral cofactors such as EBV or HHV-8 (3).
Similarly, longitudinal monitoring of cats infected with FIV5 has
documented impaired cell-mediated immunity and B-cell hyperactiv-
ity as factors that may contribute indirectly to lymphomagenesis (4),
whereas analyses of a series of FIV-associated lymphomas showed
that most of these lacked detectable viral sequences (5). Despite these
generally negative observations, a number of studies have suggested
that there may be exceptions to this rule. HIV sequences have been
detected in a number of tumors using PCR methods (6, 7). Moreover,
monoclonal integration of viral sequences in the tumor DNA was
demonstrated for one case of HIV-associated T-cell lymphoma where
viral integration was mapped to the FUR gene and was associated
with overexpression of the nearby FPS/FES proto-oncogene (8). We
reported a potentially similar observation in a case of B-cell lym-
phoma, which arose in a cat infected with FIV, where the tumor cells
harbored a single integrated proviral copy detected by Southern blot
analysis (9). Additional analysis reported here suggests that in this
case the consequence of this insertion event may be loss of function
rather than transcriptional activation of a host gene. Furthermore,
analysis of the human orthologue reveals a previously uncharacterized
gene, which maps to a site of frequent deletions and loss of heterozy-
gosity in a number of common human cancers.
Materials and Methods
Library Preparation and Screening. DNA extracted from lymphoma
Q254 (9) was digested to completion with EcoRI and size selected on a
10–40% sucrose gradient. Fragments between 9 and 13 kb were purified, and
mixed in a 1:1 molar ratio with EcoRI digested  DASH II arms (Stratagene).
After ligation and packaging with Gigapack III Gold extract (Stratagene),
0.5  106 plaques were screened with a radiolabelled probe generated by
random priming of a 1.2 kb FIV Gag-pol fragment (1242–2431; Ref. 10). After
plaque purification of positive recombinants, phage DNA was prepared and
used for analysis by restriction mapping and Southern blot hybridization. A
representative clone was selected for subcloning of the EcoRI insert into
plasmid pBR328 for additional analysis, generating the plasmid designated
pEAG6.
Sequence Analysis. DNA sequence was determined using a Thermoseque-
nase primer cycle sequencing kit (Amersham Pharmacia Biotech) with the aid
of infrared dye-labeled primers (MWG, Germany) and a LiCor 4000 auto-
mated sequencer.
Southern Blot Hybridization. Twenty-g samples of DNA were digested
with EcoRI, fragments separated on a 0.8% agarose TAE gel and transferred
onto Hybond N membrane (Amersham Pharmacia Biotech) in 20 SSC. The
filter was hybridized with a 94-bp exon 3 probe (PCR product of primers C
5-GATGAATTTTCAGGATTGTC-3 and D 5-ACCGCAGACAACTGAA-
GAG-3, fE3, Fig. 1a) in RapidHyb (Amersham Pharmacia Biotech) at 65°C,
washed 3  20 min 0.5 SSC, 0.5% SDS, 60°C, and exposed to X-ray film.
Chromosomal Assignment. Chromosomal assignment of the FIV integra-
tion site was achieved by PCR screening of feline-rodent hybrid cell lines each
containing different combinations of feline chromosomes (11). Primers (A and
B) were based on unique feline DNA sequences 5 to the integrated FIV
element (Fig. 1, a and c; A: 5-AGACATAGAAATCTCAAGCAG-3; B:
5-ACTTGCTCCTAATTTTACCC-3), which allowed the amplification of a
250-bp fragment from feline but not hamster or mouse template DNA. One-
min steps of denaturation (95°C), annealing (52°C), and DNA synthesis (72°C)
were performed using 1 g of template DNA, 50 pmol of each primer, and Taq
polymerase (Promega Corporation).
Northern Blot Analysis. A human multitissue Northern blot (Clontech)
was hybridized in RapidHyb with human EST clone (IMAGE clone 1047426)
insert, obtained from the United Kingdom MRC HGMP Resource Centre
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(accession number AA625226). Hybridization was carried out at 65°C, and
washing was performed at high stringency (3  20 min 0.1 SSC, 0.5% SDS,
60°C).
RT-PCR. Five g of total RNA samples were reverse transcribed using a
First Strand cDNA synthesis kit (Amersham Pharmacia Biotech) and NotI-dT
primer. Amplification was carried out on aliquots of one-fifth of each sample
with 30 pmol of each primer pair. Primers used included F-FLJ12973 exon 3
and 4 (exon 3 5-AAGGAAGAGACTGAAGAACA-3 and exon 4 5-TG-
GATTCAGGAGGCTGTCTC-3), FIV Gag (966F 5-GGGATTAGACAC-
TAGGCCATCTA-3, 1837R 5-GACCAGGTTTTCCACATTTATTA-3),
FIV R/U5 (5-ATTGAACCCTGTCAAGTATCT-3), or HPRT. Amplification
was performed in 1.1 Reddy Mix (ABgene) at 95°C 30 s, 55°C 30 s, and
72°C 30 s. To control for RNA integrity, HPRT amplification was found to
require 29 (C), 27 (T), and 25 (0, 1, 2, and 3) cycles (C, T, 0, 1, 2, 3; see Figure
legends). Therefore, other primer pairs were normalized to 32 (C), 30 (T), and
28 cycles (0, 1, 2, and 3). Five-l aliquots of each reaction were separated on
4% polyacrylamide gels, and detected either by staining with ethidium bromide
(Fig. 1b; Fig. 3b), or transferred onto Hybond N membrane in 20 SSC and
hybridized in 6 SSC at 65°C with either fE3 3 or HPRT probes (Fig. 3d).
Washes were 3  20 min 0.1 SSC, 0.5% SDS, 60°C (fE3) or 0.5 SSC,
0.5% SDS (HPRT).
Results and Discussion
Lymphoma Q254 arose in a specific pathogen-free cat that had
been infected with the Glasgow-8 strain of FIV for 6 years. The
tumor was extranodal, high grade, and of immature B-cell origin as
demonstrated by immunocytochemical staining and antigen receptor
gene analysis. Previous analyses also showed that the tumor DNA
contained a single integrated copy of the FIV genome, whereas
immunostaining for viral antigen was negative (9).
To characterize the inserted FIV provirus additionally, a bacteri-
ophage library was prepared from high molecular weight Q254 tumor
DNA, and this was screened with a FIV-specific gag-pol probe. Two
positive clones were obtained containing apparently identical EcoRI
inserts of 11.5 kb, and one of these was analyzed additionally after
subcloning into plasmid pBR328 to generate the plasmid clone des-
ignated pEAG6. Restriction enzyme mapping and hybridization anal-
ysis indicated the presence of an apparently full-length FIV provirus
and 2 kb of host flanking sequence. Sequence analysis confirmed
this structure, revealing a full-length FIV genome along with 1770 and
69 bp of cellular flanking sequences from the 5 and 3 ends, respec-
tively (Fig. 1a). The proviral sequence from lymphoma Q254 was
found to be very closely related to the original infecting strain (FIV-
G8), with an env gene match of 98% at the amino acid level (data
not shown).
Attempts to recover infectious virus from pEAG6 by a sensitive
transfection and coculture method (12) were unsuccessful, suggesting
that the tumor-derived viral genome carried a subtle defect that was
Fig. 1. a, diagram of plasmid pEAG6, containing integrated FIV and host flanking sequences (FIVi-1) from lymphoma Q254. The upper lines shows a partial restriction map with
sites indicated for EcoRI (E), HindIII (H), KpnI (K), and BamHI (B). The expanded line below shows the 5 600 bp of the insert with the location of a conserved exon (stippled box)
and primers used for the chromosomal mapping of the integration site (A and B) and the generation of a unique hybridization probe (C and D, probe fE3). The location of FIV genes
is indicated, with o indicating the LTRs. b, RT-PCR analysis of FIV expression in lymphoma Q254. Primers from the FIV Gag gene (966F, 1837R) were used to screen for FIV specific
products. The amplification products were separated on a polyacrylamide gel and detected by staining with ethidium bromide. Samples include Q254 lymphoma (T), salivary gland
(C). Control samples include no added RNA (0), feline fibroblast RNA (1 and 3), feline lymphoma F422 (2) and the FL4 cell line (), which is persistently infected with FIV. c,
sequence of the 5 600bp of EcoRI clone pEAG6, showing the position and sequence of a conserved exon and its match to the FLJ12973 gene on human chromosome 15. The human
DNA sequence is depicted only for the region of match. Primer sequences as defined above are underlined. d, assignment of the FIV integration site FIVi-1 to feline chromosome B3.
DNA from a series of 38 rodent x cat somatic cell hybrid clones was screened for the presence of FIVi-1 sequences by PCR using primers A and B (a and c). The histogram shows
the percentage of discordance between FIVi-1 and the specified feline chromosomes as defined by 28 established marker genes (11).
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not evident from the primary sequence. However, analysis of feline
fibroblast cells (CrFK) transfected with pEAG6 showed that FIV
structural proteins were expressed at similar levels to a control plas-
mid carrying an intact infectious molecular clone (data not shown).
These observations are interesting in the light of our previous studies,
which showed that viral sequences were not detectably expressed in
the primary tumor (9). Attempts to resolve these observations by
analysis of viral transcription in the primary tumor were severely
constrained by lack of primary tumor material, but sufficient RNA
was extracted for limited Northern blot and RT-PCR analysis.
Whereas Northern blots did not reveal any detectable FIV transcripts
(data not shown), a normalized RT-PCR analysis of tumor RNA using
FIV-specific primers revealed their presence at low levels (Fig. 1b),
suggesting that the provirus may have been expressed at low levels.
However, the possibility that this signal arose from low levels of
tumor-infiltrating lymphoid or myeloid cells could not be excluded.
Analysis of a series of feline-rodent hybrid cell lines was under-
taken to assign the FIV integration locus (FIVi-1) to a feline chromo-
some. Primers A and B (Fig. 1, a and c) were used to amplify a
fragment of 250 bp from a panel of 38 cat-rodent hybrids. The lowest
level of discordancy was noted with markers on feline chromosome
B3, providing an unambiguous assignment to this chromosome
(Fig. 1d).
Searches for matches to known genes by Basic Local Alignment
Search Tool analysis using the flanking sequences revealed a highly
significant match to a human gene (FLJ12973/Q9H967) that maps to
chromosome 15q15. This location is consistent with the presence of
an orthologue on feline chromosome B3, which displays syntenic
alignment with human chromosomes 14 and 15, and a short region of
chromosome 3 (13). The FLJ12973 gene is highly conserved, as
shown by its close homology to its murine orthologue on chromosome
2 (Q9CTV4 at band E5) and by matches to ESTs from other mam-
Fig. 2. a, Genomic structure of the human chromosome 15q15 surrounding the FLJ12973 gene, based on the draft human genome sequence.7 Exons are indicated by numbered
vertical lines and boxes along with the location of a CpG island at the 5 end of the gene. The relative position of the FIV insertion in the orthologous feline gene is indicated by an
arrow. Adjacent genes in the opposite transcriptional orientation are indicated by open boxes. The structure of spliced EST and cDNA clones is shown below based on published
sequence (AK023025) and our own analysis of an EST clone from the gene (IMAGE clone 1047426). Exon sizes are expanded for clarity. Clone 1047426 demonstrates alternative
splicing in exon 2, and a deletion between exons 9 and 13. The sequences surrounding the intra-exon deletion are shown at the bottom of the figure, with a 5-bp region of homology
underlined. b, predicted amino acid sequence of FLJ12973. The primary sequence illustrated here is the full-length 626 amino acid product predicted from cDNA AK023025. A number
of other potential initiator methionines are underlined. The first potential initiator in the EST clone (IMAGE clone 1047426) is also indicated (MCPKS), and the frame-shifted
COOH-terminal sequence of this clone is depicted underneath (bold face). The predicted amino acid sequence of the feline FLJ12973 gene between exons 3 and 5 (Fe) is also shown
in italics underneath. WD40 domains are underlined. c, structural similarity between the predicted FLJ12973 product and the human DDB2 protein. Homology between these proteins
is seen over the entire DDB2 protein and the COOH-terminus of FLJ12973, and includes a series of five tandem WD40 repeats. d, expression of FLJ12973 gene transcripts in normal
human tissues. A multitissue blot obtained from a commercial supplier (Clontech) was preloaded with poly-A RNA from various tissue sources (B, brain; H, heart; M, skeletal muscle;
C, colon; T, thymus; S, spleen; K, kidney; L, liver; I, intestine; P, placenta; Lu, lung). The blot was probed with the full-length 1.2 kb insert from the FLJ12973 EST clone (IMAGE
clone 1047426). The relative migration of size markers (4.4 and 2.4 kb) is indicated.
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malian species (data not shown). As shown in Fig. 1c, feline-human
sequence match is evident over the entire exon 3 of FLJ12973, which
is coextensive with the feline exon apart from a single codon deletion.
Homology extends 55 bp upstream and 9 bp downstream of the
canonical splice acceptor and donor signals, which mark the exon
boundaries (Fig. 1c). These observations unequivocally identify the
feline orthologue of FLJ12973 as the gene interrupted by proviral
insertion at FIVi-1 in lymphoma Q254.
The structure of the human FLJ12973 gene in Fig. 2a, which is
based on the annotated draft sequence, shows a gene comprising 13
exons and covering 40 kb of the human genome on chromosome
15q15. The first exon occurs within a CpG island, which also marks
the boundary with the next 5 gene (MFAP1), which is in the opposite
orientation. The relative position of FIV insertion in the orthologous
feline gene is also indicated, which is between exons 3 and 4, in the
same transcriptional orientation as the cellular gene. The exon struc-
ture of cDNAs derived from the human gene are indicated below,
including the full-length transcript, which was derived from the NT2
teratocarcinoma cell line (AK023035). An interesting variation
emerged from our analysis of an EST clone (IMAGE clone 1047426),
which we obtained from the United Kingdom MRC HGMP Resource
Centre (AA625226). Complete sequence analysis of this clone re-
vealed a 1126-bp insert, which differed from the full-length transcript
by an alternative splice in exon 2 and an internal deletion spanning
from the middle of exon 9 to the extreme 3 end of exon 13. The
deletion site is marked by a 5-bp homology (CCACC) between these
exons (Fig. 2a), suggesting that this is not a normal splicing variant.
Intriguingly, the same motif is repeated at the site of natural deletion
variants of the MECP2 gene, which is responsible for Rett syndrome,
a progressive neurological disorder (14). As the EST clone came from
the Soares library, which was generated from heterogenous RNA
sources, the origins of this deletion are unclear, but the possible
existence of natural variants of this gene clearly merits additional
study.
The differences between the two FLJ12973 cDNA clones create
ambiguity with respect to the predicted gene products as shown in Fig.
2b. The longest possible product is a 626 amino acid protein
(MSRSG), whereas the alternatively spliced AA625226 cDNA clones
suggests an alternative initiation (MCPKS). However, alignment with
an EST from the orthologous murine gene (AK020004) shows that
neither of these is conserved in the mouse. Use of the first conserved
initiator codon would generate a 529 amino acid protein with the
NH2-terminal sequence MKNTS. This sequence displays the closest
match to the Kozak consensus (15). Clearly, additional direct analysis
will be required to established the true NH2 terminus of FLJ12973 and
its orthologues. The truncated cDNA AA625226 also encodes a
frame-shift truncation with respect to the full-length gene product
(Fig. 2b). Notably, the insertion site of FIV between exons 3 and 4 is
3 with respect to all of these potential translational initiation sites.
Analysis of FLJ12973 for known protein family domains revealed
a series of five tandem WD40 repeats in a 250 amino acid COOH-
terminal domain (Fig. 2, b and c). This protein-protein interaction
motif is found in an expanding range of protein families of which the
roles include transcriptional regulation, apoptosis induction, and sig-
nal transduction (16). Alignment with database sequences using the
Smith and Waterman algorithm (MPSRCH)6 revealed that the closest
human gene homologue is DDB2, the small subunit of a DNA
damage-binding protein complex, which is defective in xeroderma
pigmentosum patients of complementation group E (17). As shown in
the diagram in Fig. 2c, the DDB2 protein is remarkably similar to
6 Internet address: http://www.ebi.ac.uk.
Fig. 3. a, Southern blot hybridization analysis was conducted using probe fE3 from the
FIV integration site (Fig. 1a). This analysis shows the presence of a clonal rearrangement
of the feline genome at the FIV insertion site in lymphoma Q254. The fragment size is
consistent with the presence of an integrated FIV provirus in all cells of the tumor mass,
whereas the lack of rearrangement in uninvolved tissue (salivary gland) from the same
animal (C) excludes germ-line polymorphism as the basis of this phenomenon. Other
control feline DNA samples were analyzed in Lanes 1 (AH927 fibroblast cells) and 2
(FL74 lymphoma cells). The right panel shows the results of reprobing the blot with an
FIV-specific probe (Gag-pol and Env), which shows that the single FIV copy is coincident
with the rearranged host gene fragment. b, detection of fusion transcripts in lymphoma
Q254 by RT-PCR. Primers from the FIV LTR and F-FLJ12973 exon 4 were used to screen
for fusion transcripts. The amplified products were separated on a polyacrylamide gel and
detected by ethidium bromide staining. Samples include Q254 lymphoma (T), salivary
gland (C). Control samples include no added RNA (0), feline fibroblast RNA (1), and the
FIV-infected FL4 cell line (). c, sequence of fusion transcripts derived from the FIV
insertion site. DNA sequence determination of the transcript detected in b showed that this
spans the 3 virus host junction. This structure suggests that the transcript may have arisen
from activity of the 3 LTR promoter element. FIV LTR sequence is shown in bold. Also
marked are the exon 4 splice acceptor site () and the EcoRI site, which marks the
boundary of the cloned provirus (Fig. 1a). d, RT-PCR analysis of feline FLJ12973
(F-FLJ) expression. PCR was carried out using primers derived from exons 3 and 4 of the
feline FLJ12973 orthologue (F-FLJ) or a control housekeeping gene (HPRT). The
amplified products were separated on polyacrylamide gels, blotted and probed with a
feline FLJ12973 probe (fE3) or HPRT. Samples analyzed in this way include Q254
lymphoma (T), salivary gland (C). Control samples include no added RNA (0), feline
fibroblast RNA (1 and 3), or feline lymphoma F422 (2).
7178
FIV AND HUMAN CHROMOSOME 15Q15
Research. 
on November 16, 2020. © 2002 American Association for Cancercancerres.aacrjournals.org Downloaded from 
FLJ12973 in overall structure. It shares five tandem WD40 repeats
and can be aligned with the COOH-terminal portion of FLJ12973 over
its entire length with very few gaps.
The expression pattern of the human FLJ12973 gene was explored
by Northern blot analysis using a multitissue blot (Clontech; Fig. 2d).
As can be seen from this analysis, the 1.2 kb EST probe (IMAGE
clone 1047426) detected two transcripts-a major species at around 2.8
kb and a less abundant RNA of 4.5 kb. The smaller transcript is
similar in size to that expected from the full-length cDNA sequence
(AK023035), and a notable feature is the expression of FLJ12973 in
all of the tissues examined. Expression levels varied very little across
tissues, although some differences in relative abundance of the two
transcripts were noted. Similarly, analyses of murine and feline tissue
blots showed ubiquitous and relatively uniform patterns of expression,
although in these cases only a single mRNA species was observed,
with sizes of 4.5 kb and 3.5 kb, respectively (data not shown).
In the light of the foregoing observations, it was important to
determine the effects of proviral insertion on the structure and expres-
sion of the feline FLJ12973 gene. The use of an exon 3 (fE3) probe
for Southern blot analysis of a range of feline DNA samples (Fig. 3a)
confirmed that the locus was clonally rearranged in lymphoma Q254,
which displayed an EcoRI fragment of 11.5 kb (R) corresponding
precisely to the size predicted for the cloned provirus and its flanking
sequences. A coincident fragment was detected with an FIV-specific
probe (Fig. 3a, right panel). The 2-kb EcoRI fragment corresponding
to the unoccupied FIVi-1 site (U) was proportionately reduced in
intensity in Q254 tumor DNA (T). Analysis of control tissue (C) from
the same cat excluded the possibility of an inherited polymorphism at
this locus. These results confirm that the FIV provirus was acquired
somatically in lymphoma Q254 and indicate that insertion of this
element at FIVi-1 preceded clonal expansion of the lymphoma cells.
From the position of insertion within the gene (Fig. 2a), we con-
sidered it possible that a truncated or fused mRNA species might be
generated. As discussed above, limited availability of primary tumor
material constrained expression analysis. A single Northern blot was
generated and analyzed with a probe spanning exons 3/4 of the feline
gene, revealing no detectable signal in Q254 tumor RNA (data not
shown). However, whereas this analysis ruled out gross overexpres-
sion, the low control hybridization signal meant that no conclusion
could be drawn with regard to possible transcriptional down-regula-
tion of the gene. Additional analysis by RT-PCR was undertaken to
test for the presence of fusion transcripts initiating in viral sequences.
As shown in Fig. 3b, primers spanning FIV LTR and exon 4 of
F-FLJ12973 detected a transcript specifically in RNA derived from
Q254 tumor cells, showing that read-through transcripts were indeed
present, although presumably at low levels. Sequence analysis con-
firmed that these represented unspliced transcripts containing 3LTR
and host F-FLJ12973 intron 3 sequences (Fig. 3c). To test for the
effect of insertion on the normal transcription pattern of F-FLJ12973,
RT-PCR was also carried out using primers from exons 3 and 4. As
can be seen in Fig. 3d, this assay readily detected transcripts in a range
of feline cell lines (and other tissues; data not shown), with the
exception of tumor Q254. The presence of transcripts in control tissue
(salivary gland) from the same animal demonstrated that this evident
loss of expression was not a constitutive defect.
Taken together, these results suggest that the consequence of FIV
insertion in the feline FLJ12973 gene may be loss of function. The
status of the unaffected allele in the Q254 tumor cells is of interest in
this respect. Southern blot analysis (Fig. 3a) shows a normal sized
EcoRI fragment corresponding to the unaffected allele, showing that
at least part of the normal gene was retained in the tumor cell genome.
The possibility that a deletion has occurred elsewhere in the gene
cannot be excluded, whereas it is also conceivable that epigenetic
silencing has occurred by a mechanism such as promoter hyper-
methylation, which can affect suppressor genes (18). In this respect it
is interesting to note the close structural relationship of FLJ12973 to
DDB2, one of the components of the xeroderma pigmentosum group
E complex. DNA repair defects are commonly observed in lympho-
mas, and this class of gene has also been shown to be subject to
epigenetic regulation (19). Such an event could conceivably mediate
tumor initiation, particularly in the context of a B-cell population
under proliferative stress, as seen in FIV infection (20). However,
other loss-of-function effects potentially relevant to oncogenesis
should not be discounted, as WD40 domain protein families execute
many regulatory functions (21). The possibility of a wider role for
FLJ12973 inactivation also merits additional study. Human chromo-
some 15q is the site of frequent deletions in ovarian (22) and sporadic
colorectal cancers (23), whereas the latter tumor type is also associ-
ated with an inherited susceptibility gene, CRAC1, which maps to a
similar location (24). It will clearly be important for future studies to
characterize the FLJ12973 gene in greater detail and to examine the
biological consequences of functional inactivation.
This study reveals additional evidence of the direct mutagenic
capacity of the immunosuppressive lentiviruses and their potential
contribution as direct agents in carcinogenesis. The possibility of such
a role has generally been ignored in recent analyses of AIDS-related
malignancies. Our findings should rekindle interest in this field of
study and raise awareness of the potential risks associated with
lentivirus-based vectors, which are being developed currently for
clinical use. It will be important to monitor the sites of integration of
these agents in vivo and to examine their capacity to silence as well as
activate host cell genes.
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